ArticleTherapeutic advances in hematology2026

Neutrophil-to-lymphocyte ratio half reduction as a surrogate of molecular response in polycythemia vera treated with ropeginterferon alfa-2b.

Seug Yun Yoon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.